Brain-Targeted GLP-1/GIP Agonists (e.g., Semaglutide)

About MetP Pharma

MetP Pharma is a private, platform-based biotechnology company focused on revolutionizing drug delivery via the intranasal route. Its core technology combines a proprietary semi-solid gel matrix (Silicum), a single-dose sterile applicator (Lecticula), and a scalable filling technology (Maxima) to enable efficient and targeted delivery of drugs, particularly to the central nervous system. The platform has demonstrated preclinical and clinical proof-of-concept, notably with testosterone, and is now being applied to high-value areas like GLP-1 agonists and other peptides for neurological conditions. MetP operates as both a technology licensor and an internal product developer.

Therapeutic Areas